Suppr超能文献

姐妹着丝粒的分离需要RanBP2介导的拓扑异构酶IIα的SUMO化修饰。

Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.

作者信息

Dawlaty Meelad M, Malureanu Liviu, Jeganathan Karthik B, Kao Esther, Sustmann Claudio, Tahk Samuel, Shuai Ke, Grosschedl Rudolf, van Deursen Jan M

机构信息

Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

出版信息

Cell. 2008 Apr 4;133(1):103-15. doi: 10.1016/j.cell.2008.01.045.

Abstract

RanBP2 is a nucleoporin with SUMO E3 ligase activity that functions in both nucleocytoplasmic transport and mitosis. However, the biological relevance of RanBP2 and the in vivo targets of its E3 ligase activity are unknown. Here we show that animals with low amounts of RanBP2 develop severe aneuploidy in the absence of overt transport defects. The main chromosome segregation defect in cells from these mice is anaphase-bridge formation. Topoisomerase IIalpha (Topo IIalpha), which decatenates sister centromeres prior to anaphase onset to prevent bridges, fails to accumulate at inner centromeres when RanBP2 levels are low. We find that RanBP2 sumoylates Topo IIalpha in mitosis and that this modification is required for its proper localization to inner centromeres. Furthermore, mice with low amounts of RanBP2 are highly sensitive to tumor formation. Together, these data identify RanBP2 as a chromosomal instability gene that regulates Topo IIalpha by sumoylation and suppresses tumorigenesis.

摘要

RanBP2是一种具有SUMO E3连接酶活性的核孔蛋白,在核质运输和有丝分裂中均发挥作用。然而,RanBP2的生物学相关性及其E3连接酶活性的体内靶点尚不清楚。在此我们表明,RanBP2含量低的动物在没有明显运输缺陷的情况下会出现严重的非整倍体。这些小鼠细胞中的主要染色体分离缺陷是后期桥形成。在后期开始前解开姐妹着丝粒以防止桥形成的拓扑异构酶IIα(Topo IIα),当RanBP2水平较低时无法在内着丝粒处积累。我们发现RanBP2在有丝分裂中使Topo IIα发生SUMO化,并且这种修饰是其正确定位到内着丝粒所必需的。此外,RanBP2含量低的小鼠对肿瘤形成高度敏感。总之,这些数据确定RanBP2是一个染色体不稳定基因,它通过SUMO化调节Topo IIα并抑制肿瘤发生。

相似文献

1
Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.
Cell. 2008 Apr 4;133(1):103-15. doi: 10.1016/j.cell.2008.01.045.
2
RanBP2: a tumor suppressor with a new twist on TopoII, SUMO, and centromeres.
Cancer Cell. 2008 Apr;13(4):293-5. doi: 10.1016/j.ccr.2008.03.011.
3
RanBP2 resolves sister centromeres.
Nat Cell Biol. 2008 May;10(5):512. doi: 10.1038/ncb0508-512.
4
Bloom's syndrome and PICH helicases cooperate with topoisomerase IIα in centromere disjunction before anaphase.
PLoS One. 2012;7(4):e33905. doi: 10.1371/journal.pone.0033905. Epub 2012 Apr 26.
5
PIASy-dependent SUMOylation regulates DNA topoisomerase IIalpha activity.
J Cell Biol. 2010 Nov 15;191(4):783-94. doi: 10.1083/jcb.201004033.
6
7
In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
Exp Cell Res. 2006 May 1;312(8):1418-30. doi: 10.1016/j.yexcr.2006.01.013.
8
Cohesin removal precedes topoisomerase IIα-dependent decatenation at centromeres in male mammalian meiosis II.
Chromosoma. 2014 Mar;123(1-2):129-46. doi: 10.1007/s00412-013-0434-9. Epub 2013 Sep 8.
10
SUMO modification of DNA topoisomerase II: trying to get a CENse of it all.
DNA Repair (Amst). 2009 Apr 5;8(4):557-68. doi: 10.1016/j.dnarep.2009.01.004. Epub 2009 Feb 20.

引用本文的文献

2
Nuclear pore complex protein RANBP2 and related SUMOylation in solid malignancies.
Genes Dis. 2024 Sep 4;12(4):101407. doi: 10.1016/j.gendis.2024.101407. eCollection 2025 Jul.
5
Tissue adaptation to metabolic stress: insights from SUMOylation.
Front Endocrinol (Lausanne). 2024 Nov 11;15:1434338. doi: 10.3389/fendo.2024.1434338. eCollection 2024.
6
Advances in the understanding of nuclear pore complexes in human diseases.
J Cancer Res Clin Oncol. 2024 Jul 30;150(7):374. doi: 10.1007/s00432-024-05881-5.
8
eIF4E orchestrates mRNA processing, RNA export and translation to modify specific protein production.
Nucleus. 2024 Dec;15(1):2360196. doi: 10.1080/19491034.2024.2360196. Epub 2024 Jun 16.
10
Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications.
J Cell Biol. 2023 Dec 4;222(12). doi: 10.1083/jcb.202209125. Epub 2023 Nov 13.

本文引用的文献

1
PIASgamma is required for faithful chromosome segregation in human cells.
PLoS One. 2006 Dec 20;1(1):e53. doi: 10.1371/journal.pone.0000053.
2
RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism.
PLoS Genet. 2006 Oct;2(10):e177. doi: 10.1371/journal.pgen.0020177. Epub 2006 Sep 1.
3
Does aneuploidy cause cancer?
Curr Opin Cell Biol. 2006 Dec;18(6):658-67. doi: 10.1016/j.ceb.2006.10.002. Epub 2006 Oct 12.
4
Nup214 is required for CRM1-dependent nuclear protein export in vivo.
Mol Cell Biol. 2006 Sep;26(18):6772-85. doi: 10.1128/MCB.00342-06.
5
Gene targeting methods for studying nuclear transport factors in mice.
Methods. 2006 Aug;39(4):370-8. doi: 10.1016/j.ymeth.2006.06.009.
6
The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation.
Nature. 2005 Dec 15;438(7070):1036-9. doi: 10.1038/nature04221.
7
SIZ1/SIZ2 control of chromosome transmission fidelity is mediated by the sumoylation of topoisomerase II.
Genetics. 2006 Feb;172(2):783-94. doi: 10.1534/genetics.105.047167. Epub 2005 Oct 3.
8
Beginning at the end with SUMO.
Nat Struct Mol Biol. 2005 Jul;12(7):565-6. doi: 10.1038/nsmb0705-565.
9
PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes.
EMBO J. 2005 Jun 15;24(12):2172-82. doi: 10.1038/sj.emboj.7600700. Epub 2005 Jun 2.
10
Crm1 is a mitotic effector of Ran-GTP in somatic cells.
Nat Cell Biol. 2005 Jun;7(6):626-32. doi: 10.1038/ncb1263.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验